Recurrence of mixed cryoglobulinaemia vasculitis following influenza vaccination despite clearance of hepatitis C virus infection
Sollima, S.; Milazzo, L.; Vassalini, P.; Antinori, S.; Galli, M.
Clinical and Experimental Rheumatology 36 Suppl 111(2): 161-162
2018
ISSN/ISBN: 0392-856X PMID: 29185964 Document Number: 697215
Document emailed within 1 workday
Related Documents
Garcia-Bragado, F.; Vilardell, M.; Fonollosa, V.; Ruibal, A.; Gallart, T.; Cuxart, A. 1981: Essential mixed cryoglobulinaemia and hepatitis B virus La Nouvelle Presse Medicale 10(36): 2955-2957Visentini, M.; Pascolini, S.; Mitrevski, M.; Marrapodi, R.; Del Padre, M.; Todi, L.; Camponeschi, A.; Axiotis, E.; Carlesimo, M.; De Santis, A.; Fiorilli, M.; Casato, M. 2016: Hepatitis B virus causes mixed cryoglobulinaemia by driving clonal expansion of innate B-cells producing a VH1-69-encoded antibody Clinical and Experimental Rheumatology 34(3 Suppl 97: S28-S32
Amvros'eva, T.V.; Itkin, Z.B.; Sklianskaia, E.I. 1983: Synthesis of virus-specific proteins in a mixed infection caused by various strains of influenza virus a and B Voprosy Virusologii 28(4): 90-96
Roldaan, A.C.; Masurel, N. 1983: Virus infection of the airways and influenza vaccination in patients with CARA Nederlands Tijdschrift Voor Geneeskunde 127(12): 489-492
Revenga Arranz, F.; Díaz Díaz, R.; Iglesias Díez, L.; Cassis Herce, B.; Sánchez Gómez, F.; Fuertes Ortiz, A. 1995: Cryoglobulinemic vasculitis associated with hepatitis C virus infection. A report of eight cases Acta Dermato-Venereologica 75(3): 234-236
Mao, B.; Patel, M.K.; Hennessey, K.; Duncan, R.J.W.; Wannemuehler, K.; Soeung, S.Chan. 2013: Prevalence of chronic hepatitis B virus infection after implementation of a hepatitis B vaccination program among children in three provinces in Cambodia Vaccine 31(40): 4459-4464
Oliveira, S.A.N.; Hacker, M.A.; Oliveira, M.L.A.; Yoshida, C.F.T.; Telles, P.R.; Bastos, F.I. 2005: A window of opportunity: declining rates of hepatitis B virus infection among injection drug users in Rio de Janeiro, and prospects for targeted hepatitis B vaccination Revista Panamericana de Salud Publica 18(4-5): 271-277
Alpa, M.; Ferrero, B.; Cavallo, R.; Naretto, C.; Gennaro, M.; Bellizia, L.; Sena, L.M.; Roccatello, D. 2002: Anti-GM1 and anti-sulphatide antibodies in systemic idiopathic vasculitis, systemic lupus erythematosus and mixed cryoglobulinaemia: Serum detection and clinical and electrophysiologic correlations Giornale Italiano di Nefrologia: Organo Ufficiale Della Societa Italiana di Nefrologia 19(6): 617-621
Harle, J.R.; Disdier, P.; Durand, J.M.; Alessi, M.C.; Boucraut, J.; Rouseau, J.; Kaplanski, G.; Weiller, P.J. 1991: Mixed cryoglobulinemia in hepatitis C virus infection. 10 cases Presse Medicale 20(26): 1233
Abdi, S.; Bahji, M.; Essaadouni, L.; Agoumi, N..Benkirane.; Adnaoui, M.; Tazi, Z.Mezalek.; Maaouni, A. 2004: Mixed cryoglobulinemia with monoclonal IgA and biclonal IgM during hepatitis C virus infection Annales de Biologie Clinique 62(3): 334-337
Taillan, B.; Ferrari, P.; Fuzibet, J.G.; Ferrari, E.; Quaranta, J.F.; Dujardin, P. 1991: Mixed cryoglobulinemia in hepatitis C virus infection. Value of interferon therapy Presse Medicale 20(29): 1392-1393
Hyla-Klekot, L.; Kucharska, G.; Cieslak, W. 2005: Necrotizing glomerulonephritis in decursu vasculitis after vaccination against influenza Polski Merkuriusz Lekarski: Organ Polskiego Towarzystwa Lekarskiego 19(109): 75-77
Castilla, A.; Castilla, I.; Prieto, J. 1993: Alpha-Interferon therapy for hepatitis C virus chronic infection with mixed cryoglobulinemia American Journal of Gastroenterology 88(3): 466-467
Horsmans, Y.; Tennstedt, D.; Cornu, C.; Geubel, A.P. 1998: Failure of cyclosporin therapy in type Ii mixed cryoglobulinemia associated with hepatitis C virus infection Clinical and Experimental Rheumatology 16(4): 514-515
Muñoz-Pérez, M.A.; Rodriguez-Pichardo, A.; Camacho, F.; Colmenero, M.A. 1998: Livedo reticularis and Raynaud's phenomenon associated with cryoglobulinaemia but not related to hepatitis C virus in an HIV-1-positive patient European Journal of Dermatology: Ejd 8(5): 357-358
Lumbreras, C.; Gimeno, C.; Colina, F.; Fuertes, A.; Lizasoain, M.; Aguado, J.M.; Loinaz, C.; Iglesias, J.; Moreno, E.; Noriega, A.R. 1993: Value of a new four-antigen recombinant immunoblot assay in predicting recurrence of hepatitis C virus infection following liver transplantation Transplantation Proceedings 25(1 Part 2): 1463-1465
Mader, R.; Narendran, A.; Lewtas, J.; Bykerk, V.; Goodman, R.C.; Dickson, J.R.; Keystone, E.C. 1993: Systemic vasculitis following influenza vaccination--report of 3 cases and literature review Journal of Rheumatology 20(8): 1429-1431
Nguyen, T.H.; Vu, M.H.; Nguyen, V.C.; Nguyen, L.H.; Toda, K.; Nguyen, T.N.; Dao, S.; Wannemuehler, K.A.; Hennessey, K.A. 2014: A reduction in chronic hepatitis B virus infection prevalence among children in Vietnam demonstrates the importance of vaccination Vaccine 32(2): 217-222
Stevens, C.E.; Toy, P.T.; Taylor, P.E.; Lee, T.; Yip, H.Y. 1992: Prospects for control of hepatitis B virus infection: implications of childhood vaccination and long-term protection Pediatrics 90(1 Part 2): 170-173
Stelmakh, T.A.; Medvedeva, M.N.; Golubev, D.B. 1982: Analysis of specific interactions influenza virus and cells of different sensitivity. Note 2. Characteristics of influenza virus-host cell interaction in persistent infection Virologie 33(1): 47-51